Skip to content

Progyny, Inc.

PGNY · XNAS

CIK 1551306fmd_15DRJYKCPXT2E482A52KZNYDQYServices · Services-Misc Health & Allied Services, NECTemplate: Standard

Coverage: Jan 01, 2017 to Sep 30, 2026, 36 periods

Income Statement · Annual · Millions · USD
Line itemFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues491052303455017871,0891,1671,289
Cost of revenue4186184275388620850914984
Net interest income(1)(0)(0)0013––
Gross profit7194670112167239253304
Research and development––––––––10
Selling, general and administrative1823366280144177186219
Total operating expenses1823366280144177186219
Operating income(11)(3)1083223626785
Other non-operating income (expense)(1)(3)(18)00191610
Income before taxes(12)(7)(9)93224718395
Income tax expense(0)(2)0(38)(33)(6)92937
Net income from continuing operations(12)(5)(9)466630625459
Net income(12)1(9)466630625459
Net income to common shareholders(13)(6)(9)466630625459
Progyny, Inc. (PGNY) financial statements · FinancialMD